| Home | E-Submission | Sitemap | Contact us |  
top_img
International Journal of Arrhythmia 2018;19(2): 63-81.
doi: https://doi.org/10.18501/arrhythmia.2018.007
2018 대한부정맥학회 심실빈맥 전극도자 절제술 가이드라인 Part 2
김주연1, 김성환2, 김유리3, 김윤년4, 김 준5, 김태훈6, 남기병5, 노승영7, 박경민8, 박형섭4, 박희남6, 배은정9, 오세일10, 윤남식11, 이만영12, 조영진13, 진은선14, 조용근15, 차태준16, 최종일17
1가톨릭대학교 의정부성모병원
2가톨릭대학교 서울성모병원
3가톨릭대학교 인천성모병원
4계명대학교 동산의료원
5울산대학교 서울아산병원
6연세대학교 세브란스병원
7동국대학교병원
8성균관대학교 삼성서울병원
9서울대학교 어린이병원
10서울대학교병원
11전남대학교병원
12가톨릭대학교 여의도성모병원
13분당서울대학교병원
14경희대학교 강동경희대병원
15경북대학교병원
16고신대학교 복음병원
17고려대학교 안암병원
2018 KHRS Guidelines for Catheter Ablation of Ventricular Arrhythmias – Part2
Ju-Youn Kim 1, Sung-Hwan Kim 2, Yoo Ri Kim 3, Yoon-Nyun Kim 4, Jun Kim 5, Tae-Hoon Kim 6, Gi-Byoung Nam 5, Seung-Young Roh 7, Kyoung-Min Park 8, Hyoung-Seob Park 4, Hui-Nam Pak 6, Eun-Jung Bae 9, Seil Oh 10, Namsik Yoon 11, Man Young Lee 12, Youngjin Cho 13, Yongkeun Cho 14, Eun-Sun Jin 15, Tae-Joon Cha 16, Jong-Il Choi 17
Corresponding Author: Jong-Il Choi ,Tel: +82-2-920-5445, Fax: +82-2-927-1478, Email: jongilchoi@korea.ac.kr
Received: April 23, 2018.  Accepted: June 12, 2018.
Abstract
The recommendations outlined constitute the first clinical practice guidelines of the Korean Heart Rhythm Society regarding catheter ablation of ventricular arrhythmias (VA). This is a guideline PART 2, which includes VA in the structurally normal heart, inherited primary arrhythmia syndromes, VA related to congenital heart disease, as well as VA and sudden cardiac death observed in specific populations. In the structurally normal heart, treatment is guided by the occurrence of symptoms or the frequency of arrhythmias that cause ventricular dysfunction over time. Catheter ablation can be recommended in patients in whom anti-arrhythmic medications are ineffective. The sites of origin of arrhythmic activity are known to be the outflow tract, fascicles, papillary muscle, or the annulus. Specific cardiac channelopathies include congenital long QT and Brugada syndrome. This guideline discusses the diagnostic criteria, risk stratification, and treatment of these syndromes. We have included recommendations for adult congenital heart disease. Moreover, we have discussed the management of VA occurring in specific populations such as in patients with psychiatric and neurological disorders, pregnant patients, those with obstructive sleep apnea or drug-related pro-arrhythmias, athletes, and elderly patients.